Black Diamond Therapeutics, Inc. (BDTX) DCF Valuation

Valoración de DCF de Black Diamond Therapeutics, Inc. (BDTX)

US | Healthcare | Biotechnology | NASDAQ
Black Diamond Therapeutics, Inc. (BDTX) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Black Diamond Therapeutics, Inc. (BDTX) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Diseñada para la precisión, nuestra calculadora DCF (BDTX) le permite evaluar la valoración de Black Diamond Therapeutics, Inc. utilizando datos financieros del mundo real y proporciona una flexibilidad completa para modificar todos los parámetros clave para proyecciones mejoradas.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -29.3 -66.7 -126.7 -92.3 -86.0 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .0 .6 2.2 3.2 .4 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -29.3 -67.3 -128.9 -95.6 -86.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 154.7 315.1 209.8 122.8 131.4 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable 2.0 2.5 4.1 1.9 2.3 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -.1 -2.7 -.2 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -34.2 -65.5 -126.4 -90.8 -86.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -32.2 -64.4 -125.4 -90.0 -85.6 -2.3 .0 .0 .0 .0
WACC, % 13.86 13.84 13.84 13.82 13.86 13.84 13.84 13.84 13.84 13.84
PV UFCF
SUM PV UFCF -2.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt -31
Equity Value 29
Diluted Shares Outstanding, MM 44
Equity Value Per Share 0.66

What You Will Get

  • Real BDTX Financial Data: Pre-filled with Black Diamond Therapeutics’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Black Diamond Therapeutics’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Customizable Clinical Parameters: Adjust vital inputs such as patient demographics, treatment efficacy, and trial duration.
  • Instant DCF Analysis: Provides real-time calculations for intrinsic value, NPV, and additional financial metrics.
  • Industry-Leading Precision: Leverages Black Diamond Therapeutics' (BDTX) actual financial data for accurate valuation results.
  • Simplified Scenario Testing: Easily explore various assumptions and assess different outcomes.
  • Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.

How It Works

  1. Download the Template: Gain immediate access to the Excel-based BDTX DCF Calculator.
  2. Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other key metrics.
  3. Instant Calculations: The model will automatically refresh to reflect Black Diamond Therapeutics’ intrinsic value.
  4. Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
  5. Analyze and Decide: Leverage the outcomes to inform your investment or financial analysis.

Why Choose Black Diamond Therapeutics, Inc. (BDTX)?

  • Innovative Solutions: Cutting-edge therapies that target genetic drivers of disease.
  • Scientific Expertise: Backed by a team of leading scientists and researchers in the field.
  • Patient-Centric Approach: Focused on developing treatments that improve patient outcomes.
  • Strong Pipeline: Robust portfolio of drug candidates in various stages of development.
  • Proven Track Record: Committed to delivering results that meet the highest standards of quality.

Who Should Use This Product?

  • Pharmaceutical Students: Explore drug development processes and apply them using real-world data.
  • Researchers: Integrate cutting-edge models into studies or academic projects.
  • Investors: Evaluate your investment strategies and assess the potential of Black Diamond Therapeutics, Inc. (BDTX).
  • Market Analysts: Enhance your analysis with a customizable financial model tailored for biotech companies.
  • Healthcare Entrepreneurs: Understand how biotech firms like Black Diamond Therapeutics, Inc. (BDTX) are evaluated in the market.

What the Template Contains

  • Preloaded BDTX Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
  • DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
  • Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
  • Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
  • Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
  • Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.

No products were found matching.